Abstract
In a cancer gene therapy model recombinant adenoviruses expressing the herpes simplex virus thymidine kinase (HSVtk) gene were injected into tumors in situ, either alone or in combination with adenoviruses (Avs) engineered to express IL-2, IL-6 or the costimulatory molecule B7-1. HSVtk phosphorylates the prodrug ganciclovir, thus converting it into an antimetabolite which kills not only HSVtk expressing cells, but also by the ‘bystander effect’, neighboring untransduced tumor cells. The tumors regressed in 80% of mice upon AvTK/ganciclovir treatment; combinations with AvIL-2, AvIL-6, or AvB7-1 did not improve these results. Cured mice were protected from further challenge with wild-type tumor but not from challenges with an unrelated syngeneic tumor cell line. Since cytotoxic T lymphocyte responses in this tumor model were weak, we analyzed cytokine secretion from spleen cells of treated animals. The best correlate of antitumor immunity in this model was enhanced secretion of GM-CSF, while secretion of IL-2, IL-6 and IFNγ was also frequently increased but not as consistently. The enhanced IFNγ secretion associated with unchanged IL-4 secretion suggests that AvTK treatment results in a predominantly Th1-mediated antitumor immune response.
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Felzmann, T., Ramsey, W. & Blaese, R. Characterization of the antitumor immune response generated by treatment of murine tumors with recombinant adenoviruses expressing HSVtk, IL-2, IL-6 or B7-1. Gene Ther 4, 1322–1329 (1997). https://doi.org/10.1038/sj.gt.3300533
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.gt.3300533
- Springer Nature Limited
Keywords
This article is cited by
-
Neoadjuvant in situ gene-mediated cytotoxic immunotherapy improves postoperative outcomes in novel syngeneic esophageal carcinoma models
Cancer Gene Therapy (2011)
-
Synergy of adoptive T-cell therapy and intratumoral suicide gene therapy is mediated by host NK cells
Gene Therapy (2007)
-
Adenovirus-mediated interleukin-12 gene transfer combined with cytosine deaminase followed by 5-fluorocytosine treatment exerts potent antitumor activity in Renca tumor-bearing mice
BMC Cancer (2005)
-
Antitumor immune responses mediated by adenoviral GDEPT using nitroreductase/CB1954 is enhanced by high-level coexpression of heat shock protein 70
Cancer Gene Therapy (2005)
-
Gene therapy of hepatocarcinoma: a long way from the concept to the therapeutical impact
Cancer Gene Therapy (2003)